Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $139.6 million.

  • Prestige Consumer Healthcare's Total Current Liabilities rose 3609.34% to $139.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $139.6 million, marking a year-over-year increase of 3609.34%. This contributed to the annual value of $106.6 million for FY2025, which is 890.66% down from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Total Current Liabilities is $139.6 million, which was up 3609.34% from $134.6 million recorded in Q3 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Total Current Liabilities peaked at $160.7 million during Q1 2023, and registered a low of $102.5 million during Q4 2024.
  • In the last 5 years, Prestige Consumer Healthcare's Total Current Liabilities had a median value of $132.2 million in 2023 and averaged $131.9 million.
  • In the last 5 years, Prestige Consumer Healthcare's Total Current Liabilities plummeted by 2717.05% in 2024 and then surged by 3609.34% in 2025.
  • Prestige Consumer Healthcare's Total Current Liabilities (Quarter) stood at $135.1 million in 2021, then rose by 18.54% to $160.2 million in 2022, then decreased by 20.44% to $127.4 million in 2023, then decreased by 19.53% to $102.5 million in 2024, then skyrocketed by 36.09% to $139.6 million in 2025.
  • Its last three reported values are $139.6 million in Q4 2025, $134.6 million for Q3 2025, and $109.7 million during Q2 2025.